Synthetic internal ribosome entry sites and methods of identifying same

Details for Australian Patent Application No. 2001231171 (hide)

Owner The Scripps Research Institute

Inventors Zhou, Wei; Chappell, Stephen A.; Owens, Geoffrey; Krushel, Leslie; Chappell, Gerald M.; Edelman, Gerald M; Pinkstaff, Jason K.; Mauro, Vincent P.

Agent FB Rice

Pub. Number AU-B-2001231171

PCT Pub. Number WO01/55369

Priority 60/230,852 07.09.00 US; 60/178,816 28.01.00 US; 60/207,804 30.05.00 US; 60/261,312 12.01.01 US; 60/186,496 02.03.00 US; 60/230,956 07.09.00 US

Filing date 26 January 2001

Wipo publication date 7 August 2001

Acceptance publication date 4 January 2007

International Classifications

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/79 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for eukaryotic hosts

C12N 15/90 (2006.01) Mutation or genetic engineering

Event Publications

4 January 2007 Application Accepted

  Published as AU-B-2001231171

1 February 2007 Corrigenda

  Applications Accepted - Name Index Under the name The Scripps Research Institute, Application No. 2001231171, Under INID (72) delete the co-inventor Chappell, Gerald M

3 May 2007 Standard Patent Sealed

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001231172-Methods and compositions for generating human monoclonal antibodies

2001231170